Stentys S.A.S.
Stock Exchange Euronext Paris
EPS
EUR0.22
Market Cap
EUR15.36 M
Shares Outstanding
26.82 M
Public Float
25.04 M

Profile

Address
18, rue d' Hauteville
Paris Ile-de-France 75010
France
Employees -
Website http://www.stentys.com
Updated 07/08/2019
Stentys SA engages in the design, development and marketing of self-expanding stents used in treating cardiovascular diseases. It provides innovative solutions to the interventional cardiologist to treat patients with acute myocardial infarction and other complex coronary disease. The company's products include xpositions, mistent, stentys btk, stentys ac, ses stent and stentys stent.

Financials

View All

Michel Darnaud
Chairman
Christophe Lottin
Chief Executive Officer & Director